Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

A physiologically based pharmacokinetic (PBPK) model to align dosimetry of the isobutyl metabolic series in rats and humans

Journal Article · · Regulatory Toxicology and Pharmacology
 [1];  [2];  [2];  [3]
  1. Pacific Northwest National Laboratory (PNNL), Richland, WA (United States); Oregon State Univ., Corvallis, OR (United States)
  2. Pacific Northwest National Laboratory (PNNL), Richland, WA (United States)
  3. Willem Faber Toxicology Consulting, LLC, Victor, NY (United States)

Here, we developed a physiologically based pharmacokinetic (PBPK) model in rats and humans for the isobutyl metabolic series including isobutyl acetate, isobutanol, isobutyraldehyde, and isobutyric acid. Chemical manufactures routinely use these compounds as solvents, for chemical synthesis, as potential biofuels, de-icing fluids, and additives for food and/or fragrance in consumer products. Human exposure to isobutyl compounds can occur through inhalation or oral routes. We previously developed a PBPK model for the propyl metabolic series and utilized it as a framework to create the isobutyl PBPK model due to the chemical similarities between the two series. To support model development, we measured in vitro metabolism of isobutyl acetate in rat and human blood and liver S9 fractions. Compared to rats, humans demonstrated faster isobutyl acetate hydrolysis in liver S9 fractions, while the hydrolysis rates in blood were similar between the two species. We used concentrations of isobutyl compounds measured in air and blood from rats exposed to isobutyl acetate and isobutanol as well as other published data to further parameterize the model. Following exposure to either isobutyl acetate or isobutanol, we observed isobutanol concentrations highest among the isobutyl compounds in the blood of rats. Overall, the model accurately predicts measured time course concentrations of isobutyl acetate, isobutanol, and isobutyric acid in available data in rats and humans. Sensitivity analyses identified alveolar ventilation rates, isobutyl metabolism rates, and cardiac output as the most sensitive parameters affecting concentrations of isobutyl compounds in blood. The isobutyl PBPK model enables comparisons of internal dose metrics across various isobutyl compound exposures and species and allows for calculation of equivalent external exposures that result in the same dose metric. Regulators can employ this PBPK model to predict and align internal dose metrics of isobutyl compounds for risk assessment purposes.

Research Organization:
Pacific Northwest National Laboratory (PNNL), Richland, WA (United States)
Sponsoring Organization:
USDOE
Grant/Contract Number:
AC05-76RL01830
OSTI ID:
2587785
Report Number(s):
PNNL-ACT-SA--10895
Journal Information:
Regulatory Toxicology and Pharmacology, Journal Name: Regulatory Toxicology and Pharmacology Vol. 163; ISSN 0273-2300
Publisher:
Elsevier BVCopyright Statement
Country of Publication:
United States
Language:
English

References (32)

A Priori Prediction of Tissue:Plasma Partition Coefficients of Drugs to Facilitate the Use of Physiologically‐Based Pharmacokinetic Models in Drug Discovery journal January 2000
Issues in assessing the health risks of n‐butanol journal June 2019
Theoretical Versus Empirical Allometry: Facts Behind Theories Application to Pharmacokinetics journal July 2010
A highly sensitive, simple, and fast gas chromatography–mass spectrometry method for the quantification of serum short-chain fatty acids and their potential features in central obesity journal September 2021
Metabolic fate of [1-14C]isobutyric acid in the rat journal March 1979
Hepatic alcohol dehydrogenase activity in chick hepatocytes towards the major alcohols present in commercial alcoholic beverages: Comparison with activities in rat and human liver journal January 1990
Short chain fatty acids exchange across the gut and liver in humans measured at surgery journal December 2009
Application of liquid chromatography–mass spectrometry to measure short chain fatty acids in blood journal March 2009
Development of a physiologically based pharmacokinetic model for propylene glycol monomethyl ether and its acetate in rats and humans journal March 2005
In vitro metabolism of benzo[a]pyrene-7,8-dihydrodiol and dibenzo[def,p]chrysene-11,12 diol in rodent and human hepatic microsomes journal March 2017
A human life-stage physiologically based pharmacokinetic and pharmacodynamic model for chlorpyrifos: Development and validation journal August 2014
Physiologically based pharmacokinetic modeling of ethyl acetate and ethanol in rodents and humans journal October 2015
Linking internal dosimetries of the propyl metabolic series in rats and humans using physiologically based pharmacokinetic (PBPK) modeling journal February 2020
Serum Acetate:Propionate Ratio Is Related to Serum Cholesterol in Men but Not Women journal November 1996
Family Approach for Estimating Reference Concentrations/Doses for Series of Related Organic Chemicals journal March 2000
Development of a Physiologically Based Pharmacokinetic Model of Isopropanol and Its Metabolite Acetone journal October 2001
Derivation of a Human Equivalent Concentration for n-Butanol Using A Physiologically Based Pharmacokinetic Model for n-Butyl Acetate and Metabolites n-Butanol and n-Butyric Acid journal February 2005
Development of a Physiologically Based Pharmacokinetic Model for Ethylene Glycol and Its Metabolite, Glycolic Acid, in Rats and Humans journal February 2005
Tissue Distribution, Ontogeny, and Regulation of Aldehyde Dehydrogenase (Aldh) Enzymes mRNA by Prototypical Microsomal Enzyme Inducers in Mice journal November 2007
Circulating levels of butyrate are inversely related to portal hypertension, endotoxemia, and systemic inflammation in patients with cirrhosis journal July 2019
Physiologically Based Pharmacokinetic modelling of drugs in pregnancy: A mini‐review on availability and limitations journal November 2023
Characterization of three isoenzymes of rat alcohol dehydrogenase journal January 1987
To scale or not to scale: the principles of dose extrapolation journal July 2009
Prediction of Human Drug Clearance by Multiple Metabolic Pathways: Integration of Hepatic and Intestinal Microsomal and Cytosolic Data journal May 2011
Short chain fatty acids in human large intestine, portal, hepatic and venous blood. journal October 1987
Partition coefficients of some acetate esters and alcohols in water, blood, olive oil, and rat tissues. journal January 1994
Physiological Parameter Values for Physiologically Based Pharmacokinetic Models journal July 1997
The CompTox Chemistry Dashboard: a community data resource for environmental chemistry journal November 2017
The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism journal July 2013
Scaling Factors for the Extrapolation of In Vivo Metabolic Drug Clearance From In Vitro Data: Reaching a Consensus on Values of Human Micro-somal Protein and Hepatocellularity Per Gram of Liver journal January 2007
Physiologically Based Pharmacokinetics Model in Pregnancy: A Regulatory Perspective on Model Evaluation journal June 2021
Compilation of Henry's law constants (version 4.0) for water as solvent journal January 2015